William W. Lamph
Ligand Pharmaceuticals (United States) · 97 works · 6,949 citations · h-index 40
Top works
- fos-associated cellular p39 is related to nuclear transcription factor AP-1
- Induction of proto-oncogene JUN/AP-1 by serum and TPA
- Direct interaction between fos and jun nuclear oncoproteins: role of the 'leucine zipper' domain
- Identification of a nuclear receptor that is activated by farnesol metabolites
- mXBP/CRE-BP2 and c-Jun form a complex which binds to the cyclic AMP, but not to the 12-O-tetradecanoylphorbol-13-acetate, response element.
- Arsenic Trioxide as an Inducer of Apoptosis and Loss of PML/RARα Protein in Acute Promyelocytic Leukemia Cells
- Activation of Retinoid X Receptors Induces Apoptosis in HL-60 Cell Lines
- Negative and positive regulation by transcription factor cAMP response element-binding protein is modulated by phosphorylation.
- A Retinoid-Resistant Acute Promyelocytic Leukemia Subclone Expresses a Dominant Negative PML-RARα Mutation
- Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand.
- Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.
- Mapping of epidermal growth factor-, serum-, and phorbol ester-responsive sequence elements in the c-jun promoter.
- mXBP/CRE-BP2 and c-Jun Form a Complex Which Binds to the Cyclic AMP, but Not to the 12- O -Tetradecanoylphorbol-13-Acetate, Response Element
- Loss of viral gene expression and retention of tumorigenicity by Abelson lymphoma cells
- Different genes control the susceptibility of mice to Moloney or Abelson murine leukemia viruses
- Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma.
- The retinoid X receptor-selective retinoid, LGD1069, prevents the development of estrogen receptor-negative mammary tumors in transgenic mice.
- Transformation-dependent alterations in the oligosaccharides of Prague C Rous sarcoma virus glycoproteins
- Regulation of Proto-oncogene fos: A Paradigm for Early Response Genes
- Platelet Derived Growth Factor (Pdgf), Androgens and Inflammation: Possible Etiologic Factors in the Development of Prostatic Hyperplasia